IGM Biosciences (IGMS)
(Delayed Data from NSDQ)
$16.41 USD
-0.48 (-2.84%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $16.47 +0.06 (0.37%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
IGM Biosciences, Inc. (IGMS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.80 | $48.00 | $11.00 | 29.07% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for IGM Biosciences, Inc. comes to $21.80. The forecasts range from a low of $11.00 to a high of $48.00. The average price target represents an increase of 29.07% from the last closing price of $16.89.
Analyst Price Targets (10)
Broker Rating
IGM Biosciences, Inc. currently has an average brokerage recommendation (ABR) of 1.90 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.90 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 10% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 10%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.90 | 1.90 | 1.90 | 1.90 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/5/2024 | H.C. Wainwright & Co. | Robert Burns | Hold | Hold |
8/22/2024 | Truist Securities | Asthika S Goonewardene | Strong Buy | Strong Buy |
8/15/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/14/2024 | Wedbush Securities | Robert Driscoll | Strong Buy | Strong Buy |
8/14/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/28/2024 | Guggenheim Securities | Michael Schmidt | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.90 |
ABR (Last week) | 1.90 |
# of Recs in ABR | 10 |
Average Target Price | $21.80 |
LT Growth Rate | 14.40% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.82 |
IGMS FAQs
IGM Biosciences, Inc. (IGMS) currently has an average brokerage recommendation (ABR) of 1.90 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms.
The average price target for IGM Biosciences, Inc. (IGMS) is $21.80. The current on short-term price targets is based on 8 reports.
The forecasts for IGM Biosciences, Inc. (IGMS) range from a low of $11 to a high of $48. The average price target represents a increase of $29.07 from the last closing price of $16.89.
The current UPSIDE for IGM Biosciences, Inc. (IGMS) is 29.07%
Based on short-term price targets offered by 10 analysts, the average price target for IGM Biosciences, Inc. comes to $21.80. The forecasts range from a low of $11.00 to a high of $48.00. The average price target represents an increase of 29.07% from the last closing price of $16.89.